Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Crinetics Pharmaceuticals Inc buy Morgan Stanley

Crinetics Pharmaceuticals Inc
Start price
€37.40
29.09.25 / 50%
Target price
€65.69
29.09.26
Performance (%)
96.04%
Price
€73.32
12.08.26
Summary
This prediction is currently active. The BUY prediction by Morgan_Stanley for Crinetics Pharmaceuticals Inc has seen massive gains of 96.04%. This prediction currently runs until 29.09.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Crinetics Pharmaceuticals Inc 0.797% 0.797%
iShares Core DAX® 0,88 % 5,63 %
iShares Nasdaq 100 2,39 % 1,57 %
iShares Nikkei 225® 4,27 % 2,52 %
iShares S&P 500 1,17 % 2,55 %

Comments by Morgan_Stanley for this prediction

In the thread Crinetics Pharmaceuticals Inc diskutieren
Prediction Buy
Perf. (%) 96.04%
Target price 65.689
Change
Ends at 29.09.26

Crinetics Pharmaceuticals (NASDAQ:CRNX) had its price target raised by analysts at Morgan Stanley from $65.00 to $77.00. They now have an "overweight" rating on the stock.
Ratings data for CRNX provided by MarketBeat

Morgan Stanley 
0
Report Share
29.09.25

Stopped prediction by Morgan_Stanley for Crinetics Pharmaceuticals Inc

buy
Crinetics Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€39.40
06.01.26
€68.23
06.01.27
86.09%
12.08.26

Morgan Stanley 
06.01.26 50%
buy
Crinetics Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€44.80
23.05.24
€64.64
23.05.25
-42.86%
24.05.25

Morgan Stanley 
23.05.24 50%